510(k) Report

510(k) · Cleared

Cleared

Quantex Iga

K962200510(k) TraditionalCleared Sep 25, 1996110-day reviewClass II21 CFR 866.5510

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Instrumentation Laboratory CO · CZP Iga, Antigen, Antiserum, Control

Cleared on Sep 25, 1996 as substantially equivalent to K920014 (Instrumentation Laboratory CO, 1992) after a 110-day review. Its family tree reaches back 1 generation to 1992.

Decided
Sep 25, 1996
Review
110 days
Class
Class II
Product code
CZP
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K920014 (1992). No later device cites it as a predicate yet.

K920014 · IL Test Immunoglobulin a · Instrumentation Laboratory CO · 199219901992199419961998
  1. Root · 1 generation backK920014 IL Test Immunoglobulin aInstrumentation Laboratory CO · 1992
  2. This deviceK962200 Quantex IgaInstrumentation Laboratory CO · 1996
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K920014IL Test Immunoglobulin aInstrumentation Laboratory CO1992—
0 (this device)K962200Quantex IgaInstrumentation Laboratory CO1996—
FIG. 1 — Lineage of K962200, 1992–1996Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CZP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CZP device

  1. #1 K193525 Yumizen C1200 Immunoglobulin A, Yumizen C1200…score 0.2 · 3 generations · no Class I recall
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K920014IL Test Immunoglobulin a
Summary page 1
…3000-22130 Classification name(s): 866.5510 Immunoglobulins A, G, M, D and E immunological test systems Class II Identification of predicate device(s): IL Test™ IgA #K920014/B Description of the device/intended use(s): This product permits the quantitative in vitro diagnostic determination of Immunogl…
Instrumentation Laboratory CO1992—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All CZP devices

CZP Iga, Antigen, Antiserum, Control: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CZP

1in 2020

2020: 1
2007high 1 (2020) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CZP

Too few CZP 510(k)s in any year since 2007 to give a median.

Recalls per year · CZP

1in 2022

2022: 1
2007high 1 (2022) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CZP

1in 2025

2011: 12015: 12016: 22017: 12021: 12022: 12024: 22025: 1
2007high 2 (2016) · low 0 (2007)2025

MAUDE reports naming product code CZP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—01
20120—00
20130—00
20140—00
20150—01
20160—02
20170—01
20180—00
20190—00
20201—00
20210—01
20220—11
20230—00
20240—02
20250—01
20260—0—

What is it indicated for?

This product permits the quantitative in vitro diagnostic determination of Immunoglobulin A in serum and plasma on the ILab Clinical Chemistry System by turbidimetric immunoassay method. Measurement of IgA aids in the diagnosis of abnormal protein metabolism and the body’s lack of ability to resist infectious agents.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K962200: Quantex Iga.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K962200

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026